Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of ...

Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with ...

Retatrutide, Eli Lilly’s triple-hormone obesity drug, delivers up to 28.7% weight loss and major knee pain relief in ...

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection ...

Eli Lilly drug candidate retatrutide achieved up to 28.7% weight loss and reduced knee osteoarthritis pain in a phase 3 trial of 445 adults.

Knee pain affects millions of people worldwide, often interfering with daily activities such as walking, squatting, climbing stairs, and even getting in and out of the car. It is one of the most ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

The event also highlights the importance of non-opioid therapies for managing both acute and chronic pain. Pacira BioSciences ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Nothing can impede your fitness goals quite like knee pain. Any exercise junkie knows that even the ...

Knee pain is a prevalent concern that affects millions of people around the globe, often leading to reduced mobility and a diminished quality of life. For many, traditional pain management solutions ...

In today’s fast-paced world, many individuals grapple with the discomfort associated with joint pain and muscle stiffness. This discomfort can stem from a variety of causes, including aging, injuries, ...